In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.
Oklahoma teen lives with unique skeletal disorder
Sydney Rutz is one in five billion.
OMRF accepting 2020 Fleming Scholar applications
The application deadline is Feb. 1.
OMRF adds two new principal scientists
OMRF has named Willard “Bill” Freeman and Jacquelyn Gorman to its scientific staff.
OMRF rheumatologist honored by Lupus Foundation of America
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.
